‘Take a Photograph’: Big Survival Gain in EGFR-Mutant NSCLC ...Middle East

Medscape - News
‘Take a Photograph’: Big Survival Gain in EGFR-Mutant NSCLC
Final overall survival results show amivantamab plus lazertinib beat out osimertinib for first-line treatment of advanced EGFR-mutant NSCLC, but the combination comes with more toxicities. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( ‘Take a Photograph’: Big Survival Gain in EGFR-Mutant NSCLC )

Also on site :